Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.
Shack S, Miller A, Liu L, Prasanna P, Thibault A, Samid D. Shack S, et al. Among authors: prasanna p. Clin Cancer Res. 1996 May;2(5):865-72. Clin Cancer Res. 1996. PMID: 9816242
Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate.
Samid D, Yeh A, Prasanna P. Samid D, et al. Among authors: prasanna p. Blood. 1992 Sep 15;80(6):1576-81. Blood. 1992. PMID: 1381630
Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia.
Fibach E, Prasanna P, Rodgers GP, Samid D. Fibach E, et al. Among authors: prasanna p. Blood. 1993 Oct 1;82(7):2203-9. Blood. 1993. PMID: 7691251
Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells.
Prasanna P, Thibault A, Liu L, Samid D. Prasanna P, et al. J Neurochem. 1996 Feb;66(2):710-6. doi: 10.1046/j.1471-4159.1996.66020710.x. J Neurochem. 1996. PMID: 8592143
Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers.
Samid D, Hudgins WR, Shack S, Liu L, Prasanna P, Myers CE. Samid D, et al. Among authors: prasanna p. Adv Exp Med Biol. 1997;400A:501-5. doi: 10.1007/978-1-4615-5325-0_67. Adv Exp Med Biol. 1997. PMID: 9547596 Review.
Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2'-deoxycytidine-induced carcinogenesis.
Prasanna P, Shack S, Wilson VL, Samid D. Prasanna P, et al. Clin Cancer Res. 1995 Aug;1(8):865-71. Clin Cancer Res. 1995. PMID: 9816056
Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.
Coleman CN, Higgins GS, Brown JM, Baumann M, Kirsch DG, Willers H, Prasanna PG, Dewhirst MW, Bernhard EJ, Ahmed MM. Coleman CN, et al. Clin Cancer Res. 2016 Jul 1;22(13):3138-47. doi: 10.1158/1078-0432.CCR-16-0069. Epub 2016 May 6. Clin Cancer Res. 2016. PMID: 27154913 Free PMC article. Review.
Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.
Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, Raben D, Mitchell J. Ahmed MM, et al. Cancer Res. 2018 May 1;78(9):2166-2170. doi: 10.1158/0008-5472.CAN-17-3760. Epub 2018 Apr 23. Cancer Res. 2018. PMID: 29686020 Free PMC article. No abstract available.
Normal tissue protection for improving radiotherapy: Where are the Gaps?
Prasanna PG, Stone HB, Wong RS, Capala J, Bernhard EJ, Vikram B, Coleman CN. Prasanna PG, et al. Transl Cancer Res. 2012 Jun;1(1):35-48. Transl Cancer Res. 2012. PMID: 22866245 Free PMC article.
Proto-oncogene expression: a predictive assay for radiation biodosimetry applications.
Miller AC, Luo L, Chin WK, Director-Myska AE, Prasanna PG, Blakely WF. Miller AC, et al. Among authors: prasanna pg. Radiat Prot Dosimetry. 2002;99(1-4):295-302. doi: 10.1093/oxfordjournals.rpd.a006789. Radiat Prot Dosimetry. 2002. PMID: 12194311
130 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page